Search research articles
Contact Us
Filters
Showing results (11-20 of 37) with videos related to
Page
of 4
Sort By:
Ejhaem
|
February 23, 2023
What can we do about patients presenting with myeloma and severe renal failure? Observations from the UK MERIT plasma exchange trial
Judith Behrens, Gill Gaskin, Neil Iggo, et al.
Leukemia & Lymphoma
|
September 17, 2004
Improved laboratory diagnosis of bacterial and fungal infections in patients with hematological malignancies using PCR and ribosomal RNA sequence analysis
Jiru Xu, John E Moore, B Cherie Millar, et al.
British Journal of Haematology
|
March 29, 2008
Bortezomib, doxorubicin and dexamethasone (PAD) front-line treatment of multiple myeloma: updated results after long-term follow-up
Rakesh Popat, Heather E Oakervee, Simon Hallam, et al.
Leukemia & Lymphoma
|
October 20, 2022
IgD multiple myeloma: biology, diagnosis, and treatment
Philip A Egan, Sheila J M O'Connor, W Ian Deighan, et al.
British Journal of Haematology
|
June 15, 2005
PAD combination therapy (PS-341/bortezomib, doxorubicin and dexamethasone) for previously untreated patients with multiple myeloma
Heather E Oakervee, Rakesh Popat, Nicola Curry, et al.
Haematologica
|
October 26, 2010
Efficacy and outcome of autologous transplantation in rare myelomas
Curly Morris, Mary Drake, Jane Apperley, et al.
Leukemia & Lymphoma
|
April 18, 2009
ABCB1 (MDR1) rs1045642 is associated with increased overall survival in plasma cell myeloma
Stephen Drain, Mark A Catherwood, Nick Orr, et al.
The Journal of Molecular Diagnostics : JMD
|
January 26, 2007
Telomeric IGH losses detectable by fluorescence in situ hybridization in chronic lymphocytic leukemia reflect somatic VH recombination events
Iwona Wlodarska, Christine Matthews, Ellen Veyt, et al.
Leukemia & Lymphoma
|
January 7, 2016
Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting)
Benedetto Bruno, Holger W Auner, Gösta Gahrton, et al.
British Journal of Haematology
|
November 17, 2009
Unrelated stem cell transplantation after reduced intensity conditioning for patients with multiple myeloma relapsing after autologous transplantation
Nicolaus Kröger, Avichai Shimoni, Georgia Schilling, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 37) with videos related to
Sort By:
Page
of 4
Ejhaem
|
February 23, 2023
What can we do about patients presenting with myeloma and severe renal failure? Observations from the UK MERIT plasma exchange trial
Judith Behrens, Gill Gaskin, Neil Iggo, et al.
Leukemia & Lymphoma
|
September 17, 2004
Improved laboratory diagnosis of bacterial and fungal infections in patients with hematological malignancies using PCR and ribosomal RNA sequence analysis
Jiru Xu, John E Moore, B Cherie Millar, et al.
British Journal of Haematology
|
March 29, 2008
Bortezomib, doxorubicin and dexamethasone (PAD) front-line treatment of multiple myeloma: updated results after long-term follow-up
Rakesh Popat, Heather E Oakervee, Simon Hallam, et al.
Leukemia & Lymphoma
|
October 20, 2022
IgD multiple myeloma: biology, diagnosis, and treatment
Philip A Egan, Sheila J M O'Connor, W Ian Deighan, et al.
British Journal of Haematology
|
June 15, 2005
PAD combination therapy (PS-341/bortezomib, doxorubicin and dexamethasone) for previously untreated patients with multiple myeloma
Heather E Oakervee, Rakesh Popat, Nicola Curry, et al.
Haematologica
|
October 26, 2010
Efficacy and outcome of autologous transplantation in rare myelomas
Curly Morris, Mary Drake, Jane Apperley, et al.
Leukemia & Lymphoma
|
April 18, 2009
ABCB1 (MDR1) rs1045642 is associated with increased overall survival in plasma cell myeloma
Stephen Drain, Mark A Catherwood, Nick Orr, et al.
The Journal of Molecular Diagnostics : JMD
|
January 26, 2007
Telomeric IGH losses detectable by fluorescence in situ hybridization in chronic lymphocytic leukemia reflect somatic VH recombination events
Iwona Wlodarska, Christine Matthews, Ellen Veyt, et al.
Leukemia & Lymphoma
|
January 7, 2016
Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting)
Benedetto Bruno, Holger W Auner, Gösta Gahrton, et al.
British Journal of Haematology
|
November 17, 2009
Unrelated stem cell transplantation after reduced intensity conditioning for patients with multiple myeloma relapsing after autologous transplantation
Nicolaus Kröger, Avichai Shimoni, Georgia Schilling, et al.
Page
of 4